[A case of recurrent breast cancer with life-threatening multiple lung metastasis markedly responding to CMF as third-line chemotherapy]

Gan To Kagaku Ryoho. 2006 Mar;33(3):365-7. doi: 10.2217/14750708.3.3.365.
[Article in Japanese]

Abstract

A 35-year-old woman with taxane and anthracycline-resistant recurrent breast cancer with multiple lung metastasis and carcinomatous lymphangitis was treated with CMF as third-line chemotherapy. A complete response was achieved,and the toxicities were tolerable. We thought that CMF could be a useful regimen as third-line chemotherapy for metastatic breast cancer.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anthracyclines / pharmacology
  • Antineoplastic Agents, Hormonal / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Breast Neoplasms / surgery
  • Bridged-Ring Compounds / pharmacology
  • Chemotherapy, Adjuvant
  • Cyclophosphamide / administration & dosage
  • Drug Administration Schedule
  • Drug Resistance, Neoplasm
  • Female
  • Fluorouracil / administration & dosage
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / secondary*
  • Lymphangitis / etiology
  • Methotrexate / administration & dosage
  • Quality of Life
  • Remission Induction
  • Tamoxifen / administration & dosage
  • Taxoids / pharmacology

Substances

  • Anthracyclines
  • Antineoplastic Agents, Hormonal
  • Bridged-Ring Compounds
  • Taxoids
  • Tamoxifen
  • taxane
  • Cyclophosphamide
  • Fluorouracil
  • Methotrexate

Supplementary concepts

  • CMF regimen